Facebook
Twitter
LinkedIn
ForwardNavigating the Haze: Marijuana and Changes to Federal Law
On April 30, the U.S. Drug Enforcement Administration moved to recommend reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act—the biggest drug policy shift in 50 years, with significant implications for federal grantees.
This webinar will offer key insights into what the rescheduling means and whether it sufficiently brings state legalization efforts into compliance with federal controlled substances law. It will also provide guidance on whether the loosened restrictions and increased flexibility under a Schedule III classification should prompt health centers, research institutions, and other grantees to enact changes to policies and procedures.
The on-demand version of this webinar will be available for purchase after the conclusion of the live webinar.
Target Audience
- Executive Directors
- HR Directors
- Compliance team members
- Anyone who needs to stay appraised of potential changes to drug policy
Learning Objectives
After this webinar, you will be able to:
- Understand the scope of DEA's recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act
- Discuss the likely implications and common risks for federal grantees, from health centers to research institutions
- Identify which practices, policies and processes need to be reviewed (and updated) at your organization to account for the change
Molly Evans
Molly Evans is a Partner in the firm’s Health Care practice group. She advises health centers on the management of clinical, employment and workforce-related risks, with a particular focus on professional liability, the Federal Tort Claims Act and HIPAA matters. From her experience as both a private attorney and in-house counsel, Molly knows the importance of managing liability and risk issues in mission-driven organizations. [Full Bio]
Mindy Pava
Mindy serves as a Partner in the firm’s Litigation & Government Investigations, Federal Grants, Health Care and Education practice groups, where she focuses her practice on advising federal grantees (including health centers) as they navigate all facets of administrative and judicial review. A seasoned litigator, she also represents organizations in health care and other industries in responding to civil investigative demands and federal subpoenas. [Full Bio]
Certificates of Attendance: We verify attendance upon completion of a webinar (live or recorded version) and will only issue certificates in the name of the account holder enrolled in the course. If you need to document attendance for someone other than the account holder, we provide blank Certificates of Attendance for a supervisor to sign and certify that a different individual viewed the course.
Group Attendance: Due to the online nature of webinars, we cannot verify participation by more than one person. For groups, we provide an attendance record form and blank Certificates of Attendance to record attendance at a group viewing session and document each individual's participation. We recommend that a supervisor or colleague sign the certificate to certify attendance.
Read more about maintaining an attendance record in our FAQs.
Available Credit
- 1.00 Certificate of Attendance
Price
Access to the recorded version of this webinar is included in your purchase.
You will have access to the recordings for 90 days after enrollment. Once posted to your account, you can view each webinar anytime on-demand during the access period identified in your purchase confirmation. For additional information on viewing and accessing webinars, view our full terms and conditions here.
Payment Policy
We accept the following forms of payment: American Express, Mastercard, Visa, ACH, PayPal, electronic check, and check. For information about the methods of payment we accept, please review our Payment FAQs.
Refunds/Cancellations
Review our Cancellation Policies.
Required Hardware/Software
Google Chrome and Mozilla Firefox are the preferred browsers.